Blue Cross Blue Shield of Minnesota, et. al. v. Glaxosmithkline plc, et. al.
Representation of Blues plans and other health insurers in litigation against drug manufacturer for overpayments made for the prescription drug Paxil and Paxil CR. After lengthy discovery and numerous pretrial motions on claims which included allegations of antitrust violations arising from manufacturers' use of patents to keep generics out of the market, settlement obtained in the fall of 2008.
Related Links